Advertisement
U.S. Markets closed

MediPharm Labs Corp. (MEDIF)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
0.0550-0.0032 (-5.50%)
At close: 04:00PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
22,244
33,062
22,117
21,711
36,012
-
Cost of Revenue
29,342
27,207
24,031
36,957
79,990
-
Gross Profit
-7,098
5,855
-1,914
-15,246
-43,978
-
Operating Expense
33,779
23,602
26,870
27,763
27,736
-
Operating Income
-40,877
-17,747
-28,784
-43,009
-71,714
-
Net Non Operating Interest Income Expense
343
475
448
-10,281
-7,602
-
Other Income Expense
-5,599
3,913
-1,653
-1,398
7,216
-
Pretax Income
-46,133
-13,359
-29,989
-54,688
-72,100
-
Tax Provision
7
-276
-6
113
-4,990
-
Net Income Common Stockholders
-46,140
-13,083
-29,983
-54,801
-66,353
-
Diluted NI Available to Com Stockholders
-46,140
-13,083
-29,983
-54,801
-66,353
-
Basic EPS
-0.05
-0.04
-0.11
-0.22
-0.48
-
Diluted EPS
-0.05
-0.04
-0.11
-0.22
-0.48
-
Basic Average Shares
326,694
363,324
276,861
249,907
138,549
-
Diluted Average Shares
326,694
363,324
276,861
249,907
138,549
-
Total Operating Income as Reported
-46,784
-18,252
-29,533
-48,916
-72,576
-
Rent Expense Supplemental
1,498
1,300
586
366
709
-
Total Expenses
63,121
50,809
50,901
64,720
107,726
-
Net Income from Continuing & Discontinued Operation
-46,140
-13,083
-29,983
-54,801
-66,353
-
Normalized Income
-42,781
-16,915
-28,330
-53,773
-73,070
-
Interest Income
341
840
479
225
273
-
Interest Expense
-2
365
31
10,506
7,875
-
Net Interest Income
343
475
448
-10,281
-7,602
-
EBIT
-46,135
-12,994
-29,958
-44,182
-64,225
-
EBITDA
-41,420
-10,478
-27,086
-38,549
-53,418
-
Reconciled Cost of Revenue
29,342
25,144
21,990
32,738
71,055
-
Reconciled Depreciation
4,715
2,516
2,872
5,633
10,807
-
Net Income from Continuing Operation Net Minority Interest
-46,140
-13,083
-29,983
-54,801
-66,353
-
Total Unusual Items Excluding Goodwill
-5,599
3,913
-1,653
-1,398
7,216
-
Total Unusual Items
-5,599
3,913
-1,653
-1,398
7,216
-
Normalized EBITDA
-35,821
-14,391
-25,433
-37,151
-60,634
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
-2,240
80.8435
-0.3307
-370.47
499.4153
-